T1	Pharmacological_substance 33 49	Dihydropyridines
N1000 	Reference T1 MeSH:D004095	Dihydropyridines
T2	Pharmacological_substance 125 141	dihydropyridines
N1001 	Reference T2 MeSH:D004095	dihydropyridines
T3	Pharmacological_substance 269 280	nicardipine
N1002 	Reference T3 MeSH:D009529	nicardipine
T4	Pharmacological_substance 285 298	lercanidipine
N1003 	Reference T4 MeSH:C060343	lercanidipine
T5	Pharmacological_substance 349 361	nitrendipine
N1004 	Reference T5 MeSH:D009568	nitrendipine
T6	Disorder 89 108	cutaneous eruptions
N1 	Reference T6 UMLS:C0015230	cutaneous eruptions
T7	Disorder 169 179	exanthemas
N2 	Reference T7 UMLS:C0015230	exanthemas
T8	Disorder 183 204	severe adverse events
N3 	Reference T8 UMLS:C1519275	severe adverse events
T11	Disorder 226 243	bullous eruption,
N4 	Reference T11 UMLS:C0235818	bullous eruption,
T12	Combination 281 284	and
T14	Coreferring_mention 304 317	same symptoms
T15	Disorder 0 16	Bullous Eruption
N5 	Reference T15 UMLS:C0235818	Bullous Eruption
